Rinsho Shinkeigaku (Clinical Neurology)

  • HOME
  • Rinsho Shinkeigaku (Clinical Neurology)
  • Vol.52 No.11

Vol.52 No.11 contents

Presidential Address

Roles of cerebrovascular innervations and their neurotransmitters in various pathological conditions of central nervous system

Norihiro Suzuki, M.D., Ph.D.

CLINICA NEUROL, 52: 819|824, 2012

Opening Seminar 1

The Clinical Definition of Parkinson's Disease -Time for a Change?

Werner Poewe, M.D.

CLINICA NEUROL, 52: 825|825, 2012

Opening Seminar 2

Ischemic Stroke and the Fate of Cerebral Microvessels

Gregory J. del Zoppo, M.D.

CLINICA NEUROL, 52: 826|826, 2012

Educational Lecture 1

Involuntary movements: Video presentation

Yoshikazu Ugawa, M.D.

CLINICA NEUROL, 52: 827|831, 2012

Educational Lecture 1

Recent clinical trials on treatment of myasthenia gravis

Hiroaki Yoshikawa

CLINICA NEUROL, 52: 832|835, 2012

Educational Lecture 1

Diagnostic and therapeutic scheme of autoimmune mediated encephalitis/encephalopathy

Yukitoshi Takahashi, M.D.

CLINICA NEUROL, 52: 836|839, 2012

Educational Lecture 1

Surgical therapy for entrapment neuropathy

Shigekuni Tachibana, M.D.

CLINICA NEUROL, 52: 840|843, 2012

Educational Lecture 1

Clinical genetics of amyotrophic lateral sclerosis in Japan: an update

Masashi Aoki, M.D., Hitoshi Warita, M.D., Naoki Suzuki, M.D. and Masaaki Kato, M.D.

CLINICA NEUROL, 52: 844|847, 2012

Educational Lecture 1

Correlation between EEG and neuroimaging

Shozo Tobimatsu, M.D., Ph. D.

CLINICA NEUROL, 52: 848|850, 2012

Educational Lecture 1

Neuropathology of mild cognitive impairment

Masaki Takao, M.D.

CLINICA NEUROL, 52: 851|854, 2012

Educational Lecture 1

Faculty development for neurology education

Masanaga Yamawaki

CLINICA NEUROL, 52: 855|856, 2012

Educational Lecture 2

Diagnostic approach for studying epileptic seizure

Keiko Usui, M.D., Ph.D., Kiyohito Terada, M.D., Ph.D. and Yushi Inoue, M.D., Ph.D.

CLINICA NEUROL, 52: 857|860, 2012

Educational Lecture 2

Pathophysiological regulation of cellular stress response by Keap1-Nrf2 system

Masayuki Yamamoto, M.D., Ph.D.

CLINICA NEUROL, 52: 861|861, 2012

Educational Lecture 2

Sensory input and basal ganglia

Yoshikazu Ugawa, M.D.

CLINICA NEUROL, 52: 862|865, 2012

Educational Lecture 2

Psychosomatic approach for chronic headache

Masahiro Hashizume

CLINICA NEUROL, 52: 866|868, 2012

Educational Lecture 2

Clinical points for progressive muscular dystrophy-Is immobobilization the only concernH-

Hirofumi Komaki, M.D.

CLINICA NEUROL, 52: 869|873, 2012

Educational Lecture 2

Keywords for study of pathological conditions of neurodegenerative diseases

Yoshitaka Nagai, M.D., Ph.D.

CLINICA NEUROL, 52: 874|876, 2012

Educational Lecture 2

Series of clinical ethics necessary for neurological medicine
-"Bad news telling" with a focus on notification of intractable diseases

Mieko Ogino

CLINICA NEUROL, 52: 877|877, 2012

Educational Lecture 2

Neuroimmunological diseases and pregnancy

Yuko Shimizu, M.D., Ph.D.

CLINICA NEUROL, 52: 878|881, 2012

Educational Lecture 3

Current state of recanalization therapy in acute ischemic stroke

Haruhiko Hoshino, M.D.

CLINICA NEUROL, 52: 882|884, 2012

Educational Lecture 3

Recent trend in subacute meningitides

Satoshi Kamei, M.D.

CLINICA NEUROL, 52: 885|888, 2012

Educational Lecture 3

Neurogenetics useful in clinical practice (with a focus on spinocerebellar degeneration)

Yuji Takahashi

CLINICA NEUROL, 52: 889|889, 2012

AAN-JSN Joint Symposium (2)

Medical Therapy for Parkinson's Disease
-the Current State of the Art

C. Warren Olanow, M.D.

CLINICA NEUROL, 52: 890|890, 2012

AAN-JSN Joint Symposium (2)

The Transition of Deep Brain Stimulation from Disease Specific to Symptom Specific Indications

Michael S. Okun, M.D.

CLINICA NEUROL, 52: 891|895, 2012

AAN-JSN Joint Symposium (2)

Gene therapy for Parkinson's disease

Shin-ichi Muramatsu, M.D.

CLINICA NEUROL, 52: 896|898, 2012

AAN-JSN Joint Symposium (2)

Investigation of Pathophysiology of Parkinson's Disease Using iPS Cells Technology

Hideyuki Okano, M.D.

CLINICA NEUROL, 52: 899|899, 2012

AAN-JSN Joint Symposium (2)

Novel Migraine Mechanisms as Targets for Therapy

Andrew Charles, M.D.

CLINICA NEUROL, 52: 900|900, 2012

AAN-JSN Joint Symposium (2)

Migraine Diagnosis: Screening Items, Instruments and Scales

Shuu-Jiun Wang, M.D.

CLINICA NEUROL, 52: 901|901, 2012

AAN-JSN Joint Symposium (2)

Episodic to Chronic Migraine: The Basis for the Transformation

David W. Dodick, M.D.

CLINICA NEUROL, 52: 902|902, 2012

AAN-JSN Joint Symposium (2)

Refractory Migraine: Mechanisms and Management

Yasuo Terayama, M.D.

CLINICA NEUROL, 52: 903|903, 2012

Symposium 1

CREB activation is a key player for ischemic tolerance in the brain

Kazuo Kitagawa, M.D., Tsutomu Sasaki, M.D., Yasukazu Terasaki, M.D., Yoshiki Yagita, M.D. and Hideki Mochizuki, M.D.

CLINICA NEUROL, 52: 904|907, 2012

Symposium 1

Molecular mechanism and new protective strategy for ischemic white matter damages

Takao Urabe, M.D., Ph.D.

CLINICA NEUROL, 52: 908|910, 2012

Symposium 1

Novel neuroprotective agents: a HIF activator and an Akt activator

Shunya Takizawa1), Eiichiro Nagata1) and Hongbo R. Luo2)

CLINICA NEUROL, 52: 911|912, 2012

Symposium 1

Biphasic Inflammatory Responses in Injury and Repair after Stroke

Eng H. Lo, M.D.

CLINICA NEUROL, 52: 913|913, 2012

Symposium 1

Guillain-Barré and Fisher syndromes: update on the pathophysiological role of antiganglioside antibodies

Kenichi Kaida, M.D.

CLINICA NEUROL, 52: 914|916, 2012

Symposium 1

Recent topics of chronic inflammatory demyelinating polyneuropathy

Masahiro Iijima

CLINICA NEUROL, 52: 917|919, 2012

Symposium 1

Multifocal motor neuropathy: Current review of epidemiology and treatment

Naoko Matsui, M.D.

CLINICA NEUROL, 52: 920|922, 2012

Symposium 1

Treatment for POEMS syndrome: The current status and tasks for the future

Sonoko Misawa, M.D.

CLINICA NEUROL, 52: 923|924, 2012

Symposium 1

Ideal subspecialty training in the field of neurology\Competence required for the experts: Neurophysiology

Nobuo Kohara, M.D.

CLINICA NEUROL, 52: 925|926, 2012

Symposium 1

Competence required for neuroimaging abilities in neurologists

Hidenao Fukuyama, M.D., Ph.D.

CLINICA NEUROL, 52: 927|930, 2012

Symposium 1

Practical approach to neuropathology required for experts

Mari Yoshida, M.D., Ph.D.

CLINICA NEUROL, 52: 931|932, 2012

Symposium 1

Subspeciality Training for Neurologists-Neurogenetics

Tatsushi Toda

CLINICA NEUROL, 52: 933|933, 2012

Symposium 1

The fate of injured motor neurons and the behavior of surrounding glial cells

Hiroshi Kiyama, Ph.D.

CLINICA NEUROL, 52: 934|936, 2012

Symposium 1

Exploring the neural diseases using stem cell technology

Wado Akamatsu

CLINICA NEUROL, 52: 937|938, 2012

Symposium 1

Regenerating neurons by using endogenous neuronal progenitor cells

Kazunobu Sawamoto, Ph.D.

CLINICA NEUROL, 52: 939|941, 2012

Symposium 1

Therapeutic role of regenerative factor "HGF" in ALS and other neurodegenerative disorders

Hiroshi Funakoshi1) and Toshikazu Nakamura2)

CLINICA NEUROL, 52: 942|942, 2012

Symposium 1

Iron metabolism in the central nervous system

Kunihiro Yoshida, M.D.

CLINICA NEUROL, 52: 943|946, 2012

Symposium 1

Clinical features of superficial siderosis

Takemori Yamawaki, M.D., Ph.D.

CLINICA NEUROL, 52: 947|950, 2012

Symposium 1

Clinical feature of neuroferritinopathy

Emiko Ohta

CLINICA NEUROL, 52: 951|954, 2012

Symposium 1

Imaging of diseases with iron deposition

Suketaka Momoshima, M.D.

CLINICA NEUROL, 52: 955|958, 2012

Symposium 1

Neuropathology of superficial hemosiderosis and neuroferritinopathy

Masaki Takao, M.D.

CLINICA NEUROL, 52: 959|961, 2012

Symposium 1

Prevalence of dementia in Japan: past, present and future

Takashi Asada, M.D.

CLINICA NEUROL, 52: 962|964, 2012

Symposium 1

Depression, motor function and cognitive function in epidemiological study

Kenji Wada, M.D. and Kenji Nakashima, M.D.

CLINICA NEUROL, 52: 965|967, 2012

Symposium 1

Non-genetic risk factors for dementia

Naoyuki Sato, M.D.

CLINICA NEUROL, 52: 968|970, 2012

Symposium 1

Triptans and Calcitonin gene-related peptide (CGRP) receptor antagonists

Kiyoshi Negoro, M.D., Ph.D.

CLINICA NEUROL, 52: 971|972, 2012

Symposium 1

Drugs for migraine prophylaxis

Takao Takeshima, M.D., Ph.D.

CLINICA NEUROL, 52: 973|975, 2012

Symposium 1

Treatment of chronic migraine and medication overuse headache

Junichi Hamada, M.D.

CLINICA NEUROL, 52: 976|977, 2012

Symposium 1

Anti-NMDA receptor encephalitis: Pathogenic mechanisms and treatment algorithm

Josep Dalmau, M.D.

CLINICA NEUROL, 52: 978|978, 2012

Symposium 1

Associated tumors in patients with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis

Makoto Hara, M.D., Akihiko Morita, M.D. and Satoshi Kamei, M.D.

CLINICA NEUROL, 52: 979|981, 2012

Symposium 1

Localization of NMDAR-related epitopes in ovarian teratoma: comparison between patients and controls

Naoko Tachibana, M.D.1)and Shu-ichi Ikeda, M.D.2)

CLINICA NEUROL, 52: 982|984, 2012

Symposium 1

Clinical profiles of Japanese patients with anti-NMDAR encephalitis and functional analysis of the anti-NMDAR antibodies

Keiko Tanaka, M.D.

CLINICA NEUROL, 52: 985|987, 2012

Symposium 1

What is ataxia?-Towards developing a new scale for ataxia

Osamu Onodera, M.D.

CLINICA NEUROL, 52: 988|989, 2012

Symposium 1

Cerebellar internal clock: its neural mechanisms and functional roles

Tadashi Yamazaki

CLINICA NEUROL, 52: 990|993, 2012

Symposium 1

Memory transfer in cerebellar motor learning

Soichi Nagao

CLINICA NEUROL, 52: 994|996, 2012

Symposium 1

Ataxic dysarthria

Yukiko Ikui

CLINICA NEUROL, 52: 997|1000, 2012

Symposium 1

Cerebellum and eye movement control
-Neuronal mechanisms of memory-based smooth-pursuit and their early clinical application-

Kikuro Fukushima1), Junko Fukushima2), Norie Ito3), Hidetoshi Takei4), Kunihiro Ikeno4), Peter M Olley1), Susumu Chiba3), Nobuyoshi Kobayashi3), Kiyoharu Inoue3) and Tateo Warabi1)3)

CLINICA NEUROL, 52: 1001|1005, 2012

Symposium 1

Cortical spreading depression and molecular genetics in migraine

Hisanori Kowa, M.D., Ph.D. and Kenji Nakashima, M.D., Ph.D.

CLINICA NEUROL, 52: 1006|1008, 2012

Symposium 1

Monitoring cerebral blood volume changes during migraine attack by using near-infrared spectroscopy

Yuka Watanabe, M.D., Ph.D., Hideaki Tanaka, M.D., Ph.D., Ryotaro Takashima, M.D., Ph.D., Masatsugu Takano, M.D., Kazuhito Kimoto, M.D. and Koichi Hirata, M.D., Ph.D.

CLINICA NEUROL, 52: 1009|1011, 2012

Symposium 1

Mechanisms underlying migraine chronification

Mamoru Shibata

CLINICA NEUROL, 52: 1012|1013, 2012

Symposium 1

Identification of biomarkers associated with migraine

Eiichiro Nagata, M.D.

CLINICA NEUROL, 52: 1014|1017, 2012

Symposium 1

Misregulation of alternative splicing and microRNA processing in DM1 pathogenesis

Denis Furling, Ph.D.

CLINICA NEUROL, 52: 1018|1022, 2012

Symposium 1

Repeat-Associated Diseases, Mutagenesis, Pathogenesis, and Therapeutic Avenues

Christopher E. Pearson, M.D.

CLINICA NEUROL, 52: 1023|1023, 2012

Symposium 1

What is professionalism?

Sadayoshi Ohbu, M.D. MMedSc (Clin. Epid), F.A.C.P.

CLINICA NEUROL, 52: 1024|1026, 2012

Symposium 1

CLINICA NEUROL, 52: 1027|1027, 2012

Symposium 1

Professionalism and the Japanese Society of Neurology-For the next 100 years-

Hidehiro Mizusawa, M.D., Ph.D.

CLINICA NEUROL, 52: 1028|1030, 2012

Symposium 1

Perspective of graduate medical education in the Japanese Society of Neurology

Masatoyo Nishizawa, M.D.

CLINICA NEUROL, 52: 1031|1032, 2012

Symposium 1

Epilepsy and law

Masato Matsuura

CLINICA NEUROL, 52: 1033|1035, 2012

Symposium 1

Building epilepsy care network in Japan

Taisuke Otsuki, M.D., Ph.D.

CLINICA NEUROL, 52: 1036|1038, 2012

Symposium 1

Long-term perspectives of epilepsy treatment and care

Yushi Inoue, M.D.

CLINICA NEUROL, 52: 1039|1042, 2012

Symposium 2

The MG-QOL15 Japanese version: validation and associations with clinical factors

Masayuki Masuda, M.D.1), Kimiaki Utsugisawa, M.D.2), Shigeaki Suzuki, M.D.3), Yuriko Nagane, M.D.2), Suguru Ito, M.D.1), Chiaki Kabasawa, M.D.4), Yasushi Suzuki, M.D.5), Yuko Shimizu, M.D.4), Hiroya Utsumi, M.D.1), Kazuo Fujihara, M.D.6), Shinichiro Uchiyama, M.D.4) and Norihiro Suzuki, M.D.3)

CLINICA NEUROL, 52: 1043|1046, 2012

Symposium 2

Directions for use of corticosteroids and calcineurin inhibitors against generalized myasthenia gravis: therapeutic strategies that can lead to early improvements and veer away from high-dose oral corticosteroids

Kimiaki Utsugisawa, M.D.1), Yuriko Nagane, M.D.1), Shigeaki Suzuki, M.D.2) and Norihiro Suzuki, M.D.2)

CLINICA NEUROL, 52: 1047|1050, 2012

Symposium 2

Plasmapheresis and immunoglobulin therapy

Hidenori Matsuo

CLINICA NEUROL, 52: 1051|1052, 2012

Symposium 2

Indication of extended thymectomy in patients with myasthenia gravis

Hiroaki Yoshikawa

CLINICA NEUROL, 52: 1053|1055, 2012

Symposium 2

Intracellular seeded aggregation of TDP-43

Takashi Nonaka and Masato Hasegawa

CLINICA NEUROL, 52: 1056|1058, 2012

Symposium 2

Whether or not ALS lesions spread contiguously?

Tadashi Kanouchi1), Teruhiko Sekiguchi2), Hidehiro Mizusawa2) and Takanori Yokota2)

CLINICA NEUROL, 52: 1059|1061, 2012

Symposium 2

The spread pattern and survival in sporadic ALS

Fumiharu Kimura, M.D., Ph.D.

CLINICA NEUROL, 52: 1062|1065, 2012

Symposium 2

Prognosis of amyotrophic lateral sclerosis in relation with pathological pattern of propagation

Shigeo Murayama1) and Yuko Saito2)

CLINICA NEUROL, 52: 1066|1067, 2012

Symposium 2

Dystonia as a common status against a common belief

Takahiro Mezaki, M.D., Ph.D.

CLINICA NEUROL, 52: 1068|1070, 2012

Symposium 2

Hereditary dystonia -Phenotype of DYT1-

Fusako Yokochi, M.D.

CLINICA NEUROL, 52: 1071|1073, 2012

Symposium 2

New medications for dystonia

Yoshimichi Miyazaki, M.D., Kenta Sato, M.D., Hidetaka Koizumi, M.D., Wataru Sako, M.D., Koutaro Asanuma, M.D. and Ryuji Kaji, M.D.

CLINICA NEUROL, 52: 1074|1076, 2012

Symposium 2

Neurosurgical management of dystonias

Takaomi Taira, M.D., Ph.D.

CLINICA NEUROL, 52: 1077|1079, 2012

Symposium 2

Physicians' emotional barriers toward epilepsy surgery

Nobukazu Nakasato, M.D.1), Kazutaka Jin, M.D.1), Masaki Iwasaki, M.D.2), Naoshi Itabashi, M.D.1) and Teiji Tominaga, M.D.2)

CLINICA NEUROL, 52: 1080|1082, 2012

Symposium 2

Epilepsy and associated disorders

Naoki Akamatsu

CLINICA NEUROL, 52: 1083|1083, 2012

Symposium 2

Clinical epileptology and clinical system neuroscience: two sides of the same coin

Riki Matsumoto, M.D., Ph.D.1), Takeharu Kunieda, M.D., Ph.D.2), Ryosuke Takahashi, M.D., Ph.D.1) and Akio Ikeda, M.D., Ph.D.1)

CLINICA NEUROL, 52: 1084|1087, 2012

Symposium 2

Clinical application of newer anti-epileptic drugs

Kiyohito Terada, M.D. and Yushi Inoue, M.D.

CLINICA NEUROL, 52: 1088|1090, 2012

Symposium 2

How to cope with psychiatric illness in patients with epilepsy

Kousuke Kanemoto, M.D., Ph.D., Yukari Tadokoro, M.D., Ph.D. and Tomohiro Oshima, M.D., Ph.D.

CLINICA NEUROL, 52: 1091|1093, 2012

Symposium 2

CLINICA NEUROL, 52: 1094|1094, 2012

Symposium 2

The indication of DBS in Parkinosn's disease (from a neurosurgical standpoint)

Chikashi Fukaya1), Kazutaka Kobayashi1)2), Hideki Oshima1)2), Takamitsu Yamamoto1) and Yoichi Katayama2)

CLINICA NEUROL, 52: 1095|1097, 2012

Symposium 2

The indication of DBS in Parkinson' disease (from a neurological standpoint)

Hitoshi Yamada, M.D., Ph.D.

CLINICA NEUROL, 52: 1098|1099, 2012

Symposium 2

The role of neurologists in deep brain stimulation for Parkinson disease: a neurosurgical perspective

Atsushi Umemura, M.D.

CLINICA NEUROL, 52: 1100|1102, 2012

Symposium 2

The role of neurologists in DBS treatment on Parkinson's disease

Yasushi Shimo, M.D., Ph.D.

CLINICA NEUROL, 52: 1103|1105, 2012

Symposium 2

Cerebral microbleeds: clinical features and management

Yusuke Yakushiji, M.D. and Hideo Hara, M.D.

CLINICA NEUROL, 52: 1106|1109, 2012

Symposium 2

Medical therapy for intracranial hemorrhage: Update Blood pressure management for prevention and acute treatment

Masatoshi Koga1) and Kazunori Toyoda2)

CLINICA NEUROL, 52: 1110|1112, 2012

Symposium 2

Management of intracranial hemorrhage during anticoagulant therapy with warfarin or novel anticoagulants

Masahiro Yasaka, M.D., Ph.D. and Yasushi Okada, M.D., Ph.D.

CLINICA NEUROL, 52: 1113|1116, 2012

Symposium 2

How to Train Stroke Neurologists

Shinichiro Uchiyama, M.D., Ph.D.

CLINICA NEUROL, 52: 1117|1119, 2012

Symposium 2

Training stroke neurologists`A proposal from a neurosurgeon`

Susumu Miyamoto, M.D., Ph.D.

CLINICA NEUROL, 52: 1120|1122, 2012

Symposium 2

Proposals of undergraduate and postgraduate education to raise stroke-conscious neurologists

Etsuro Mori, M.D.

CLINICA NEUROL, 52: 1123|1125, 2012

Symposium 2

Requisites for the leader of a stroke team

Kazuo Minematsu, M.D., Ph.D.

CLINICA NEUROL, 52: 1126|1127, 2012

Symposium 2

The skill of the stroke physician and the acquirement method

Kazumi Kimura, M.D.

CLINICA NEUROL, 52: 1128|1130, 2012

Symposium 2

How to promote lifetime education of stroke medicine for neurologist

Masayasu Matsumoto, M.D., Ph.D.

CLINICA NEUROL, 52: 1131|1133, 2012

Symposium 2

Modeling familial Alzheimer's disease with induced pluripotent stem cells

Takuya Yagi1), Daisuke Ito1), Yohei Okada2)3), Wado Akamatsu2), Yoshihiro Nihei1), Hideyuki Okano2) and Norihiro Suzuki1)

CLINICA NEUROL, 52: 1134|1136, 2012

Symposium 2

ALS patient-specific iPS cells

Haruhisa Inoue

CLINICA NEUROL, 52: 1137|1138, 2012

Symposium 2

Challenge toward gene-therapy using iPS cells for Duchenne muscular dystrophy

Mitsuo Oshimura, D.Sc., Yasuhiro Kazuki, Ph.D. and Narumi Uno, MS

CLINICA NEUROL, 52: 1139|1142, 2012

Symposium 2

iPS cell transplantation for ischemic brain

Koji Abe, M.D., Toru Yamashita, M.D. and Hiromi Kawai, M.D.

CLINICA NEUROL, 52: 1143|1146, 2012

Symposium 2

Regeneration of the damaged CNS using human iPSCs-derived neural progenitor cells

Hideyuki Okano

CLINICA NEUROL, 52: 1147|1147, 2012

Symposium 2

Anti-SRP myopathy: different entity from myositis

Shigeaki Suzuki, M.D., Ph.D.

CLINICA NEUROL, 52: 1148|1150, 2012

Symposium 2

Myofibrillar myopathies

Satoshi Nakano

CLINICA NEUROL, 52: 1151|1153, 2012

Symposium 2

Recent advances in facioscapulohumeral muscular dystrophy

Yukiko K. Hayashi1)2), Kanako Goto1)2) and Ichizo Nishino1)2)

CLINICA NEUROL, 52: 1154|1157, 2012

Symposium 2

Molecular Targeting Therapy for Fukuyama Muscular Dystrophy

Tatsushi Toda, Mariko Taniguchi-Ikeda and Kazuhiro Kobayashi

CLINICA NEUROL, 52: 1158|1158, 2012

Symposium 2

Congenital myasthenic syndromes

Kinji Ohno, M.D., Ph.D.

CLINICA NEUROL, 52: 1159|1161, 2012

Symposium 2

A pathogenic mechanism of N-terminally pyroglutamylated Aβ and possible application of Alzheimer's disease by inhibition of the pyroglutamylation

Nobuhisa Iwata, Ph.D. and Masashi Asai, Ph.D.

CLINICA NEUROL, 52: 1162|1164, 2012

Symposium 2

Development of Alzheimer's disease treatment based on the molecular mechanism of γ-secretase activity

Taisuke Tomita, M.D.

CLINICA NEUROL, 52: 1165|1167, 2012

Symposium 2

Development of antibodies for immunotherapy of Alzheimer's disease

Shin-ei Matsumoto, Ph.D.1), Haifeng Jin, Ph.D.1), Kazuya Takeda, Ph.D.1), Yukako Hasegawa1), Yumiko Motoi, M.D., Ph.D.1)2), Nobutaka Hattori, M.D., Ph.D.1)2) and Takeshi Tabira, M.D., Ph.D.1)

CLINICA NEUROL, 52: 1168|1170, 2012

Symposium 2

Alzheimer disease and tau protein

Toshihisa Tanaka, Daisuke Mayuyama and Masatoshi Takeda

CLINICA NEUROL, 52: 1171|1173, 2012

Symposium 2

Contribution of brain function analysis to the evolution of neurorehabilitation

Ichiro Miyai1), Masahito Mihara1)2), Noriaki Hattori1), Megumi Hatakenaka1), Teiji Kawano1) and Hajime Yagura1)

CLINICA NEUROL, 52: 1174|1177, 2012

Symposium 2

Development of newer rehabilitative measures for hemiparetic upper limb after stroke

Meigen Liu, M.D.

CLINICA NEUROL, 52: 1178|1181, 2012

Symposium 2

Stimulation of primary motor cortex and reorganization of cortical function

Youichi Saitoh, Koichi Hosomi and Tomoyuki Maruo

CLINICA NEUROL, 52: 1182|1184, 2012

Symposium 2

A new neuroscientific approach using decoded neurofeedback (DecNef)

Kazuhisa Shibata

CLINICA NEUROL, 52: 1185|1187, 2012

Symposium 2

Strategy on dealing with noisy NIRS data: implications on functional neuroimaging on swallowing

Ippeita Dan1), Toshifumi Sano1), Haruka Dan2) and Eiju Watanabe2)

CLINICA NEUROL, 52: 1188|1190, 2012

Symposium 2

Cortical activity in swallowing movement

Masanaga Yamawaki

CLINICA NEUROL, 52: 1191|1191, 2012

Symposium 2

Effects of pharyngeal electrical stimulation on the swallowing reflex and its possible clinical application

Makoto Inoue, D.D.S., Ph.D.

CLINICA NEUROL, 52: 1192|1194, 2012

Symposium 2

Therapeutic approach targeting TRP channels and development of anti-aspiration drugs

Satoru Ebihara

CLINICA NEUROL, 52: 1195|1197, 2012

Symposium 2

Pathophysiology of movement disorders

Atsushi Nambu

CLINICA NEUROL, 52: 1198|1200, 2012

Symposium 2

Pathophysiology of Parkinson's disease from the viewpoint of deep brain stimulation

Hirokazu Iwamuro, M.D., Ph.D.

CLINICA NEUROL, 52: 1201|1203, 2012

Symposium 2

Abnormal plasticity and drug effect in Parkinson's disease

Hiroyuki Enomoto and Yoshikazu Ugawa

CLINICA NEUROL, 52: 1204|1206, 2012

Symposium 3

Anti-androgen therapy for spinal and bulbar muscular atrophy (SBMA)

Masahisa Katsuno, M.D.1), Haruhiko Banno, M.D.1)2), Keisuke Suzuki, M.D.1), Atsushi Hashizume, M.D.1), Hiroaki Adachi, M.D.1), Fumiaki Tanaka, M.D.1)3) and Gen Sobue, M.D.1)

CLINICA NEUROL, 52: 1207|1209, 2012

Symposium 3

Sialic acid supplementation therapy for distal myopathy with rimmed vacuoles (GNE myopathy)

Ichizo Nishino, M.D., Ph.D. and Satoru Noguchi, M.D.

CLINICA NEUROL, 52: 1210|1212, 2012

Symposium 3

Gene therapy with oligonucleotides for neurological diseases

Takanori Yokota, M.D.

CLINICA NEUROL, 52: 1213|1213, 2012

Symposium 3

Clinical translation of hepatocyte growth factor for amyotrophic lateral sclerosis

Hitoshi Warita, M.D., Ph.D., Masaaki Kato, M.D., Ph.D., Naoki Suzuki, M.D., Ph.D., Yasuto Itoyama, M.D., Ph.D. and Masashi Aoki, M.D., Ph.D.

CLINICA NEUROL, 52: 1214|1217, 2012

Symposium 3

Frontotemporal lobar degeneration (FTLD)-changes of its concept and classification based on aggregated proteins

Imaharu Nakano, M.D.

CLINICA NEUROL, 52: 1218|1220, 2012

Symposium 3

Conjoint pathological cascades mediated by RNA-binding proteins, TDP-43, FUS and Ataxin-2

Daisuke Ito, M.D., Ph.D.

CLINICA NEUROL, 52: 1221|1223, 2012

Symposium 3

Aphasia and related impairments pertaining to FTLD

Mika Otsuki, M.D., Ph.D.

CLINICA NEUROL, 52: 1224|1227, 2012

Symposium 3

CLINICA NEUROL, 52: 1228|1228, 2012

Symposium 3

Selection and optimization of therapy for progressive type multiple sclerosis

Masaaki Niino, M.D., Ph.D.

CLINICA NEUROL, 52: 1229|1230, 2012

Symposium 3

Neuromyelitis optica

Ichiro Nakashima, M.D., Ph.D.

CLINICA NEUROL, 52: 1231|1233, 2012

Symposium 3

Neuro-Behçet disease and neuro-Sweet disease

Kinya Hisanaga

CLINICA NEUROL, 52: 1234|1236, 2012

Symposium 3

Central nervous system involvement of sarcoidosis: diagnosis and management

Toshihide Kumamoto, M.D.

CLINICA NEUROL, 52: 1237|1239, 2012

Symposium 3

Diagnosis and treatments of Hashimoto's encephalopathy

Makoto Yoneda, M.D.

CLINICA NEUROL, 52: 1240|1242, 2012

Symposium 3

Electrodiagnosis in plexopathies; an update

Mana Higashihara, M.D.1) and Masahiro Sonoo, M.D.2)

CLINICA NEUROL, 52: 1243|1245, 2012

Symposium 3

Reference values for concentric needle single fiber EMG

Norito Kokubun, M.D.

CLINICA NEUROL, 52: 1246|1248, 2012

Symposium 3

Non-invasive quantitative EMG: invention of the "Clustering Index (CI)" method

Haruo Uesugi, M.D.1), Masahiro Sonoo, M.D.2)/, Mana Higashihara, M.D.3), Erik Stalberg, M.D.4) and Hisatoshi Saito, M.D.5)

CLINICA NEUROL, 52: 1249|1251, 2012

Symposium 3

The electrophysiologic diagnosis for muscle ion channelopathies

Yumiko Arimura, M.D.1), Tomonori Nakamura, M.D.1), Michiyoshi Yoshimura, M.D.1), Akiko Uehara, M.D.1), Kimiyoshi Arimura, M.D.1)2), Shin-ichi Sakoda, M.D.1) and Hiroshi Takashima, M.D.1)

CLINICA NEUROL, 52: 1252|1255, 2012

Symposium 3

The contributions to clinical neurology of the axonal excitability property measurements

Kazuaki Kanai, M.D.

CLINICA NEUROL, 52: 1256|1258, 2012

Symposium 3

Glucose intolerance in myotonic dystrophy type 1

Hiroto Takada, M.D.1), Yoshinobu Oyama, M.D.1), Seiko Kon, M.D.1) and Takashi Goto, M.D.2)

CLINICA NEUROL, 52: 1259|1260, 2012

Symposium 3

Management of atrioventricular conduction abnormalities in myotonic dystrophy

Takuhisa Tamura

CLINICA NEUROL, 52: 1261|1263, 2012

Symposium 3

Clinical features and care of patients with congenital and childhood-onset myotonic dystrophy

Keiko Ishigaki, M.D., Ph.D.1), Ayako Muto, M.D., Ph.D.2) and Makiko Osawa, M.D., Ph.D.1)

CLINICA NEUROL, 52: 1264|1266, 2012

Symposium 3

Myotonic dystrophy type 2

Takashi Kimura, M.D., Ph.D.

CLINICA NEUROL, 52: 1267|1269, 2012

Symposium 3

Molecular mechanism of botlinum toxin therapy for spasticity

Takashi Sakamoto, M.D.

CLINICA NEUROL, 52: 1270|1271, 2012

Symposium 3

Treatment and indication of botulinum toxin type A for limb spasticity
-Can we break the 6 months barrier?

Ai Miyashiro, M.D.

CLINICA NEUROL, 52: 1272|1274, 2012

Symposium 3

Botulinum toxin treatment and rehabilitation; Motion analysis for reconstruction of movement

Eiichi Saitoh, Hitoshi Kagaya and Hiroki Tanikawa

CLINICA NEUROL, 52: 1275|1275, 2012

Symposium 3

Cardiovascular autonomic function and brain imaging

Masato Asahina, M.D., Ph.D.

CLINICA NEUROL, 52: 1276|1278, 2012

Symposium 3

Anterior prefrontal cortex and serotonergic system activation during Zen meditation practice induces negative mood improvement and increased alpha band in EEG

Hideho Arita, M.D.

CLINICA NEUROL, 52: 1279|1280, 2012

Symposium 3

Brain imaging and gastrointestinal function

Shin Fukudo, MD, PhD

CLINICA NEUROL, 52: 1281|1281, 2012

Symposium 3

Brain imaging and bladder function

Ryuji Sakakibara, M.D.

CLINICA NEUROL, 52: 1282|1285, 2012

Symposium 3

Imaging analysis of central nerve system for sexual arousal and sexual interest

Akira Tsujimura, Hiroshi Kiuchi, Tetsuya Takao, Yasushi Miyagawa and Norio Nonomura

CLINICA NEUROL, 52: 1286|1286, 2012

Symposium 3

The practical use of acupuncture and moxibustion treatment cooperated with neurological practice

Satoru Yamaguchi, Ph.D.1) and Nobuo Araki, M.D., Ph.D.2)

CLINICA NEUROL, 52: 1287|1289, 2012

Symposium 3

Acupuncture for painful diabetic neuropathy

Daichi Kasuya, M.D.

CLINICA NEUROL, 52: 1290|1293, 2012

Symposium 3

Mechanisms of acupuncture and moxibustion on symptoms of neurology

Kazunori Itoh, Shingo Saito, Shunsaku Sahara and Yuki Naitoh

CLINICA NEUROL, 52: 1294|1296, 2012

Symposium 3

Acupuncture; as a valuable tool for headache

Haruki Toriumi, Taeko Ebine, Toshiya Kuroi, Shibata Mamoru, Toshihiko Shimizu and Norihiro Suzuki

CLINICA NEUROL, 52: 1297|1298, 2012

Symposium 3

Application of acupuncture as a headache management tool

Sninya Manaka, M.D.

CLINICA NEUROL, 52: 1299|1302, 2012

Symposium 3

Progress of myasthenia gravis: discovery of Lrp4 antibodies

Masakatsu Motomura, M.D.1) and Osamu Higuchi, Ph.D.2)

CLINICA NEUROL, 52: 1303|1305, 2012

Symposium 3

Anti-MuSK antibodies in myasthenia gravis block binding of collagen Q to MuSK

Kinji Ohno, M.D.

CLINICA NEUROL, 52: 1306|1308, 2012

Symposium 3

The impairment of excitation-contraction (E-C) coupling in myasthenia gravis

Tomihiro Imai, M.D., Ph.D.

CLINICA NEUROL, 52: 1309|1311, 2012

Symposium 3

New clinical entity of myasthenia gravis with autoimmune targets of heart and skeletal muscles

Shigeaki Suzuki, M.D., Ph.D.

CLINICA NEUROL, 52: 1312|1314, 2012

Symposium 3

Muscle fiber atrophy

Ikuya Nonaka, M.D.

CLINICA NEUROL, 52: 1315|1317, 2012

Symposium 3

Spatial orientation under microgravity

Izumi Koizuka

CLINICA NEUROL, 52: 1318|1320, 2012

Symposium 3

Sleep and biological rhythm in space

Kazuo Mishima, M.D., Ph.D.

CLINICA NEUROL, 52: 1321|1324, 2012

Symposium 3

Prion-like protein propagation in neurodegenerative diseases

Masato Hasegawa1), Takashi Nonaka1), Masami Suzukake1), Hiroshi Tsuji1)2), Akira Tamaoka2), Mari Yoshida3), Shigeo Murayama4), Tetsuaki Arai5) and Haruhiko Akiyama6)

CLINICA NEUROL, 52: 1325|1326, 2012

Symposium 3

Molecular mechanism of early-onset familial PD

Shigeto Sato

CLINICA NEUROL, 52: 1327|1328, 2012

Symposium 3

Is "Non-Cell Autonomous" neuron death common to neurodegenerative diseases?

Koji Yamanaka, M.D., Ph.D.

CLINICA NEUROL, 52: 1329|1331, 2012

Symposium 3

Aiming to develop biochemical biomarkers for Parkinson's disease and related disorders

Takahiko Tokuda, M.D.

CLINICA NEUROL, 52: 1332|1334, 2012

Symposium 3

CLINICA NEUROL, 52: 1335|1335, 2012

Symposium 3

One year after the Great Tohoku Disaster

Masashi Aoki, M.D.

CLINICA NEUROL, 52: 1336|1338, 2012

Symposium 3

One year after the earthquake in Fukushima

Yoshikazu Ugawa, M.D.

CLINICA NEUROL, 52: 1339|1342, 2012

Symposium 3

The Great East Japan Earthquake: One year at a private hospital in Miyagi prefecture

Jinichi Saito

CLINICA NEUROL, 52: 1343|1344, 2012

Symposium 3

The events of the last one year in Fukushima Hamadori

Hareaki Seki, Nobuhito Oda and Takashi Aita

CLINICA NEUROL, 52: 1345|1347, 2012

Symposium 3

Rescue system establishment for neurological patients in case of Natural Disastrous Emergency

Koji Abe, M.D.

CLINICA NEUROL, 52: 1348|1350, 2012

Symposium 3

Novel remyelination strategy for multiple sclerosis in the era of oligodendrocytopathy

Jin Nakahara, M.D., Ph.D.

CLINICA NEUROL, 52: 1351|1353, 2012

Symposium 3

Connexin astrocytopathy and novel therapeutic strategy targeting connexin hemichannels in demyelinating disease

Katsuhisa Masaki, M.D., Ph.D.

CLINICA NEUROL, 52: 1354|1356, 2012

Symposium 3

Strategies of myelin regeneration with optogenetically controlled glial cells

Makoto Sawada

CLINICA NEUROL, 52: 1357|1359, 2012

Symposium 3

Consideration of the pathogenesis of CARASIL

Hiroaki Nozaki, M.D., Ph.D.

CLINICA NEUROL, 52: 1360|1362, 2012

Symposium 3

Clinical manifestations and neuroradiological findings of CARASIL with a novel mutation

Mamoru Shibata

CLINICA NEUROL, 52: 1363|1364, 2012

Symposium 3

Disturbance in neurovascular unit plays a pivotal role in pathophysiology of small vessel disease in the brain

Yoshiaki Itoh, M.D., Haruki Toriumi, M.D., Taeko Ebine, M.D., Miyuki Unekawa, M.D., Satoshi Yamada, M.D., Fumie Konoeda, M.D., Kenzo Koizumi, M.D., Yutaka Tomita, M.D. and Norihiro Suzuki, M.D.

CLINICA NEUROL, 52: 1365|1368, 2012

Symposium 3

Ataxic form of Hashimoto's encephalopathy

Makoto Yoneda, M.D.

CLINICA NEUROL, 52: 1369|1371, 2012

Symposium 3

The mechanism, diagnosis and treatment of HHV-6B encephalitis

Tetsushi Yoshikawa, M.D., Ph.D.

CLINICA NEUROL, 52: 1372|1374, 2012

Symposium 3

Development of therapeutic interventions for prion disease

Yoshio Tsuboi1) and Katsumi Doh-ura2)

CLINICA NEUROL, 52: 1375|1375, 2012

Symposium 3

Neuroimaging investigation in psychiatry

Toshiaki Onitsuka, M.D., Ph.D.

CLINICA NEUROL, 52: 1376|1378, 2012

Symposium 3

Neuropsychological approach to elucidating delusion and psychotic symptoms

Motoichiro Kato, M.D.

CLINICA NEUROL, 52: 1379|1381, 2012

Symposium 3

Neuropsychological aspects of neurological diseases

Mitsuru Kawamura, M.D.

CLINICA NEUROL, 52: 1382|1382, 2012

Late Breaking Symposium-1

Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): its clinical concept and the review of the previously reported cases

Shu-ichi Ikeda, M.D.

CLINICA NEUROL, 52: 1383|1385, 2012

Late Breaking Symposium-2

Adult-onset hereditary leukoencephalopathy: classification and molecular basis of the disorder

Takeshi Ikeuchi, M.D., Ph.D.

CLINICA NEUROL, 52: 1386|1389, 2012

Late Breaking Symposium-3

Hereditary diffuse leukoencephalopathy with neuroaxonal spheroids (HDLS) in early-onset dementia

Akira Tamaoka, M.D.1), Akihide Mochizuki, M.D.2), Akiko Ishii, M.D.1), Tetsuto Yamaguchi, M.D.1), Megumi Akamatsu, M.D.1) and Hiroshi Takuma, M.D.1)

CLINICA NEUROL, 52: 1390|1392, 2012

Symposium 1

Myotonic dystrophy-from pathomechanism as a RNA disease to future clinical trials

Masanori P. Takahashi, M.D.

CLINICA NEUROL, 52: 1393|1396, 2012